These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Glucagon-induced alterations of plasma levels of cyclic AMP and glucose in patients with liver disease. Klotz U; Antonin KH Z Gastroenterol; 1984 Mar; 22(3):147-52. PubMed ID: 6326401 [TBL] [Abstract][Full Text] [Related]
3. Effect of glucagon on net splanchnic cyclic AMP production in normal and diabetic men. Liljenquist JE; Bomboy JD; Lewis SB; Sinclair-Smith BC; Felts PW; Lacy WW; Crofford OB; Liddle GW J Clin Invest; 1974 Jan; 53(1):198-204. PubMed ID: 4357612 [TBL] [Abstract][Full Text] [Related]
4. Effect of propranolol on the plasma cyclic AMP and cyclic GMP levels to massive doses of glucagon in euthyroid and hyperthyroid subjects. Földes J; Gyertyánfy G; Piroska E; Juhász J Acta Med Acad Sci Hung; 1977; 34(4):227-34. PubMed ID: 218419 [TBL] [Abstract][Full Text] [Related]
5. [The effect of thyroid function on the increase of plasma cyclic AMP following glucagon injection (author's transl)]. Jäckel W; Heimes J; Herrmann J J Clin Chem Clin Biochem; 1980 Dec; 18(12):909-15. PubMed ID: 6259272 [TBL] [Abstract][Full Text] [Related]
6. Effect of alcohol on the plasma cAMP response to glucagon. French SW; Ihrig TJ; Pettit NB Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):209-12. PubMed ID: 229531 [TBL] [Abstract][Full Text] [Related]
7. [Effect of glucagon on blood gastrin levels in hepatic cirrhosis: correlation with blood levels of cyclic AMP]. Francavilla A; Sansonno D; Ierardi E; Amoruso A Boll Soc Ital Biol Sper; 1980 Dec; 56(24):2588-93. PubMed ID: 6258616 [TBL] [Abstract][Full Text] [Related]
8. Effects of beta-adrenergic blockade on plasma cyclic AMP and blood sugar responses to glucagon and isoproterenol in man. Messerli FH; Kuchel O; Tolis G; Hamet P; Fraysse J; Genest J Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):189-94. PubMed ID: 187546 [TBL] [Abstract][Full Text] [Related]
9. Plasma cyclic AMP response to glucagon as an index of tissue responsiveness to thyroid hormone. Paisey R; Elkeles RS; Hambley J; Belchetz PE Diabete Metab; 1978 Dec; 4(4):267-70. PubMed ID: 215472 [TBL] [Abstract][Full Text] [Related]
10. [Experimental study of orthotopic liver transplantation in dog--with reference to change of hepatic function, serum insulin, glucagon, c-AMP after liver transplantation and the viability of the graft]. Ohno Y Nihon Geka Gakkai Zasshi; 1988 Aug; 89(8):1192-203. PubMed ID: 2847004 [TBL] [Abstract][Full Text] [Related]
11. [Oral glucose tolerance test and glucagon loading test as useful parameters for evaluating liver functional reserve]. Lu MD Zhonghua Wai Ke Za Zhi; 1993 Sep; 31(9):532-5. PubMed ID: 8033715 [TBL] [Abstract][Full Text] [Related]
12. [Effects of intravenous perfusion of glucagon on plasma concentrations of glucose, insulin and cyclic AMP in patients with hepatic cirrhosis]. Conde Yagüe R; Gutiérrez-Cortines Corral MD; Ledesma Castaño F; González Coterillo T; Valle Cagigas M; González Puerta C Rev Clin Esp; 1985 Oct; 177(5):209-11. PubMed ID: 3001846 [No Abstract] [Full Text] [Related]
13. Ratio of circulating follistatin and activin A reflects the severity of acute liver injury and prognosis in patients with acute liver failure. Lin SD; Kawakami T; Ushio A; Sato A; Sato S; Iwai M; Endo R; Takikawa Y; Suzuki K J Gastroenterol Hepatol; 2006 Feb; 21(2):374-80. PubMed ID: 16509861 [TBL] [Abstract][Full Text] [Related]
14. The cyclic AMP response to glucagon. Comparison of tissue and plasma cyclic AMP levels in the rabbit. Jerums G; Hardy KJ; Eisman JA Diabetes; 1977 Feb; 26(2):81-8. PubMed ID: 190072 [TBL] [Abstract][Full Text] [Related]
15. Hyperglucagonemia in hepatic cirrhosis: its relation to hepatocellular dysfunction and normalization on recovery. Kabadi UM; Eisenstein AB; Tucci J; Pellicone J Am J Gastroenterol; 1984 Feb; 79(2):143-9. PubMed ID: 6364796 [TBL] [Abstract][Full Text] [Related]
16. The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy. Cheng JB; Watson JW; Pazoles CJ; Eskra JD; Griffiths RJ; Cohan VL; Turner CR; Showell HJ; Pettipher ER J Pharmacol Exp Ther; 1997 Feb; 280(2):621-6. PubMed ID: 9023272 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of the impairment of the glucagon-stimulated phosphoenolpyruvate carboxykinase gene expression by interleukin-6 in rat hepatocytes: inhibition of the increase in cyclic 3',5' adenosine monophosphate and the downstream cyclic 3',5' adenosine monophosphate action. Christ B; Nath A; Jungermann K Hepatology; 1997 Jul; 26(1):73-80. PubMed ID: 9214454 [TBL] [Abstract][Full Text] [Related]
18. Effects of propranolol and hemodialysis on the response of glucose, insulin, C-peptide and cyclic AMP to glucagon challenge. Pun KK; Yeung CK; Ho PW; Lin HJ; Chan MK; Yeung RT Clin Nephrol; 1984 Apr; 21(4):235-40. PubMed ID: 6329569 [TBL] [Abstract][Full Text] [Related]
19. Anomalous adenosine cyclic 3':5'-monophosphate responses to glucagon in patients with hepatocellular carcinoma. Pun KK; Ho PW; Yeung RT Cancer Res; 1986 Apr; 46(4 Pt 2):2152-4. PubMed ID: 3004721 [TBL] [Abstract][Full Text] [Related]